The new indication for rosuvastatin is unlikely to have any significant impact on clinical practices because of questions about its clinical utility.
Ogochukwu C. Molokwu, PharmD, MScMed
Advertisement
Articles by Ogochukwu C. Molokwu, PharmD, MScMed
Advertisement
Latest Updated Articles
- Statin Therapy for Elevated hsCRP: More Evidence Is Needed
August 11th 2010
Advertisement
Advertisement
Trending on AJMC
1
Tec-Dara Shows MRD-Negative, PFS Benefit in High-Risk Myeloma, But Longer Follow-Up Needed: Rahul Banerjee, MD
2
Early Treatment Succeeds in CRC With Next Generation KRAS Inhibitor Calderasib Plus Cetuximab Combo
3
emtelligent Turns Unstructured Clinical Data Into Actionable Insights
4
Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure
5